The Food and Drugs Authority (FDA) has denied claims circulating on social media that a paracetamol tablet called “P-500” is being sold in Ghana. The Authority clarified that it has not registered or approved for sale any such tablet in Ghana, and that the information in circulation is false and unsubstantiated. The FDA also reassured the public that it has not received any reports of hospitalization associated with the use of any paracetamol tablet.
The fake alert claims that the “P-500” paracetamol tablet is manufactured by Indians and Chinese to reduce the population of Africans, particularly Ghanaians. However, the FDA has advised the public to disregard the false information and help curb the spread of it. The Authority further urged the public to only purchase medicines from approved locations such as pharmacies, over-the-counter medicine sellers, and healthcare facilities.
The spread of false information about pharmaceuticals is a cause for concern, especially during a global health crisis. False information about drugs can lead to dangerous consequences, including people taking counterfeit medicines that may contain harmful substances. It is, therefore, crucial for regulatory bodies such as the FDA to swiftly debunk false information and ensure public safety.
For the most part, the FDA has been working tirelessly to ensure that only safe and efficacious medicines are available on the Ghanaian market. The Authority is responsible for the registration, inspection, and monitoring of medicines and medical devices to ensure their quality, safety, and efficacy. It is also involved in public education campaigns to raise awareness about the dangers of counterfeit medicines and the importance of purchasing medicines from approved sources.
In a nutshell, the false alert about the “P-500” paracetamol tablet is not true, and the FDA has advised the public to disregard it. The Authority continues to work towards ensuring that only safe and effective medicines are available in Ghana, and urges the public to be vigilant when purchasing medicines.